Literature DB >> 1311364

Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line.

J H Sinclair1, J Baillie, L A Bryant, J A Taylor-Wiedeman, J G Sissons.   

Abstract

We have previously shown that a major site of persistence of human cytomegalovirus (HCMV) in healthy carriers is in peripheral blood monocytes. However, monocytes are difficult to infect in vitro with HCMV, and HCMV gene expression cannot be reproducibly detected in peripheral blood cells of healthy carriers. Here we show that the monocytic cell line THP1 is non-permissive for HCMV infection due to a block in expression of the HCMV major immediate early (IE) promoter. This repression is correlated with the presence of a differentiation-specific cellular factor which binds to the imperfect dyad symmetry and the 21 bp enhancer repeats of the major IE promoter regulatory region and which has characteristics of MBF1, a factor which we have previously defined in HCMV non-permissive, undifferentiated teratocarcinoma cells. Both differentiation of THP1 cells into macrophages, which results in a decrease in this factor, or deletion of the factor's binding sites from the IE promoter/enhancer lifts this repression and permits expression from the major IE promoter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311364     DOI: 10.1099/0022-1317-73-2-433

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  52 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Viral binding-induced signaling drives a unique and extended intracellular trafficking pattern during infection of primary monocytes.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Patrizia Caposio; Andrew D Yurochko
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication.

Authors:  Jens Reinhardt; Geoffrey B Smith; Christopher T Himmelheber; Jane Azizkhan-Clifford; Edward S Mocarski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Chromatin-mediated regulation of cytomegalovirus gene expression.

Authors:  Matthew B Reeves
Journal:  Virus Res       Date:  2010-09-25       Impact factor: 3.303

5.  Repression by a differentiation-specific factor of the human cytomegalovirus enhancer.

Authors:  T H Huang; T Oka; T Asai; T Okada; B W Merrills; P N Gertson; R H Whitson; K Itakura
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

6.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells.

Authors:  G Hahn; R Jores; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.

Authors:  J L Meier; J A Pruessner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene.

Authors:  T Murayama; Y Ohara; M Obuchi; K S Khabar; H Higashi; N Mukaida; K Matsushima
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

10.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.